
Emilio Torres at IV CONGRESO CÓRNEA COLOMBIA 2025
The Congreso Córnea Colombia provided an important platform for scientific exchange, and the warm hospitality of the Colombian community made the experience particularly meaningful. ELZA

The Congreso Córnea Colombia provided an important platform for scientific exchange, and the warm hospitality of the Colombian community made the experience particularly meaningful. ELZA

From 12–15 September 2025, the ELZA team will be at the ESCRS Annual Meeting in Copenhagen. Learn more…

Human lens OCT maps refractive index and strain, offering new insights into accommodation, ageing, and ocular biomechanics.

We are proud to announce that ELZA Institute’s CEO, Nikki L. Hafezi MAS IP ETHZ, will serve as Course Director for a new international program in Uzbekistan — the “Professional Development Course in Visual Sciences and Public Health”.

A new publication in JRS reports the long-term endothelial safety of the ELZA-sub400 protocol for treating progressive keratoconus in corneas thinner than 400 µm.

Transepithelial corneal cross-linking offers a new epi-on CXL protocol with biomechanical outcomes comparable to accelerated epi-off CXL for keratoconus treatment

At first glance, the numbers are reassuring. Over 90% of contact lens wearers in Switzerland feel they’re well-informed about handling their lenses. But ask them

Prof. Farhad Hafezi joins the Academia Ophthalmologica Internationalis at its 50th Anniversary General Assembly in Leiden, June 2025.

Dr. Kaweh Mansouri discusses glaucoma, AI, and modern eye care on Thomas Meyer’s podcast. ELZA Eye Institute Zurich.

Dion Paridaens shared updates at SOE and SECOP 2025, highlighting his and ESOPRS’s role in advancing oculoplastics across Europe.
Stay informed & get the newsletter
You have successfully joined our subscriber list.
Newsletter abonnieren & informiert bleiben
Sie haben sich erfolgreich in unsere Abonnentenliste eingetragen.
Bitte bestätigen Sie Ihr Abonnement, indem Sie auf den Link in der E-Mail klicken, die wir Ihnen gerade geschickt haben.